2021
DOI: 10.1080/14756366.2021.1977931
|View full text |Cite
|
Sign up to set email alerts
|

A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 37 publications
(37 reference statements)
0
7
0
Order By: Relevance
“…Because these antibiotics have the same mode of action involving the inhibition of protein synthesis, measuring the IC 50 using the E. coli S30 extract system would provide IC 50 values under membrane-free conditions (Figures S14 and S15). If an antibiotic passes through the OM freely by 1403, its IC 50 value should correlate with its MIC value with 1403.…”
Section: Resultsmentioning
confidence: 99%
“…Because these antibiotics have the same mode of action involving the inhibition of protein synthesis, measuring the IC 50 using the E. coli S30 extract system would provide IC 50 values under membrane-free conditions (Figures S14 and S15). If an antibiotic passes through the OM freely by 1403, its IC 50 value should correlate with its MIC value with 1403.…”
Section: Resultsmentioning
confidence: 99%
“…White powder; yield: 42.5%; mp: 99.9− 102.8 °C; 1 H NMR (400 MHz, CDCl (24). White powder; yield: 39.8%; mp: 89.4−93.2 °C; 1 H NMR (400 MHz, CDCl (25). White powder; yield: 31.6%; mp: 106.8− 108.7 °C; 1 H NMR (400 MHz, CDCl (26) Hz, 1H, H13), 1.15 (s, 3H, H18), 1.10 (dd, J = 13.6, 4.4 Hz, 1H, H8), 0.87 (d, J = 7.2 Hz, 3H, H17), 0.70 (d, J = 6.8 Hz, 3H, H16); 13 C NMR (101 MHz, CDCl 3 ): δ(ppm) 216.9 (C3), 169.0 (C21), 168.8, 154.5, 139.0 (C19), 136.9, 129.1, 129.0, 119.3, 117.2 (C20), 74.6 (C11), 72.9, 68.5 (C14), 59.6 (C22), 58.1 (C4), 52.6, 52.3, 52.2, 50.6, 48.0, 45.4 (C9), 45.0 (C13), 44.2, 43.9 (C12), 41.7 (C5), 36.7 (C6), 36.0 (C10), 34.4 (C2), 30.4 (C8), 26.8 (C7), 26.4 (C18), 24.8 (C1), 16 H6, H7, H1, OH), 1.42 (s, 3H, H15), 1.35 (dd, J = 14.4, 3.2 Hz 1H, H7), 1.27 (d, J = 16.0 Hz, 1H, H13), 1.15 (s, 3H, H18), 1.10 (dd, J = 13.6, 4.4 Hz, 1H, H8), 0.87 (d, J = 6.8 Hz, 3H, H17), 0.70 (d, J = 6.8 Hz, 3H, H16); 13 C NMR (101 MHz, CDCl 3 ): δ(ppm) 216.9 (C3), 169.0 (C21), 168.8, 154.4, 139.0 (C19), 137.4, 131.9, 119.6, 117.2 (C20), 116.7, 74.6 (C11), 72.9, 68.5 (C14), 59.6 (C22), 58.1 (C4), 52.6, 52.3, 52.2, 50.6, 47.9, 45.4 (C9), 45.0 (C13), 44.2, 43.9 (C12), 41.7 (C5), 36.7 (C6), 36.0 (C10), 34.4 (C2), 30 (30).…”
Section: Synthesis Of 22-(piperazine-1-yl)-22-deoxypleuromutilin (14)mentioning
confidence: 99%
“…From the four marketed pleuromutilin derivatives, it can be seen that the introduction of an aliphatic thioether linker is beneficial for enhancing activity, so mercaptoethylamine was chosen. In addition, many compounds containing nitrogen structure at the C-14 side chain have also been reported to have good activities recently, , and a more water-soluble structure piperazine was used as the connecting unit as well. In order to simplify the linker and ensure the inclusion of heteroatom, a nitrogen atom directly connected was adopted additionally.…”
mentioning
confidence: 99%
“…[1,2] Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycinresistant Enterococcus (VRE) have emerged as predominant cause of nosocomial infections and can induce a wide spectrum of diseases associated with high morbidity and mortality. [3][4][5][6] Studies have shown that biofilm formation is a common defense mechanism of drug-resistant bacteria, and approximately 65-80 % of bacterial infections are biofilmassociated. [7][8][9] Thus, the development of new antibiofilm agents against S. aureus and E. faecalis has become an urgent task.…”
Section: Introductionmentioning
confidence: 99%
“…Bacteria that can resist clinical antibiotics pose a serious threat to public health around the world and bring a great economic burden to human beings [1,2] . Drug‐resistant bacteria such as methicillin‐resistant Staphylococcus aureus (MRSA) , vancomycin‐resistant Enterococcus (VRE) have emerged as predominant cause of nosocomial infections and can induce a wide spectrum of diseases associated with high morbidity and mortality [3–6] . Studies have shown that biofilm formation is a common defense mechanism of drug‐resistant bacteria, and approximately 65–80 % of bacterial infections are biofilm‐associated [7–9] .…”
Section: Introductionmentioning
confidence: 99%